| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.145 | - | 21.860 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 3.145 | - | 21.862 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 31 | - | 3.753 | 3.422 | 0 | 0 | 0 | 0 | 16.851 |
| Gross Profit/Loss - EUR | - | 3.114 | - | 18.109 | -3.421 | 0 | 0 | 0 | 0 | -16.851 |
| Net Profit/Loss - EUR | - | 3.020 | - | 17.453 | -3.421 | 0 | 0 | 0 | 0 | -16.851 |
| Employees | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Voimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 153 | - | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.229 | - | 31.521 | 27.365 | 23.952 | 23.421 | 22.277 | 22.209 | 17.698 |
| Inventories | - | 0 | - | 344 | 337 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | - | 1.324 | 1.163 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 3.229 | - | 29.853 | 25.865 | 23.952 | 23.421 | 22.277 | 22.209 | 17.698 |
| Shareholders Funds | - | 3.064 | - | 28.386 | 24.415 | 23.952 | 23.421 | 49 | 49 | -16.803 |
| Social Capital | - | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 317 | - | 3.178 | 2.950 | 0 | 0 | 22.228 | 22.161 | 34.501 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Voimed S.r.l.